{
  "id": "sttn2",
  "display_name": "Hmg Coa Reducatace Inhibitors (Statins) (SHHS2)",
  "description": "Participant taking HMG COA REDUCATACE INHIBITORS (STATINS) within two weeks of the SHHS2 visit.  All medications were recorded during the interview, and medication information was later categorized by physician review.",
  "type": "choices",
  "domain": "noyes01",
  "labels": [
    "STTN2",
    "3-hydroxy-3-methylglutaryl-coenzyme A",
    "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
    "Pharmaceutical Preparations"
  ],
  "hybrid": {
    "VARNUM": "309",
    "TABLE": "SHHS2",
    "LABEL": "HMG COA REDUCATACE INHIBITORS (STATINS)",
    "sensitivity": "0",
    "design_name": "Medication Form (SHHS2)",
    "MEMNAME": "shhs2_1",
    "design_file": "SHHS2 Medications (MD).pdf",
    "PARENT TERM": null
  }
}
